236 related articles for article (PubMed ID: 31166506)
1. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
2. [Incorporation of technologies by the Canadian and Brazilian health systems: prospects for progress in assessment processes].
Silva HPD; Elias FTS
Cad Saude Publica; 2019 Aug; 35(suppl 2):e00071518. PubMed ID: 31432894
[TBL] [Abstract][Full Text] [Related]
3. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
4. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
5. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
[TBL] [Abstract][Full Text] [Related]
6. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
7. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
9. [Innovation in health care: the role of HTA in the introduction of new technologies].
Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
[TBL] [Abstract][Full Text] [Related]
10. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
Caetano R; Hauegen RC; Osorio-de-Castro CGS
Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
[TBL] [Abstract][Full Text] [Related]
11. Health technology assessment.
Hailey D
Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
[TBL] [Abstract][Full Text] [Related]
12. [Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?].
Campolina AG; Soárez PC; Amaral FVD; Abe JM
Cad Saude Publica; 2017 Oct; 33(10):e00045517. PubMed ID: 29091169
[TBL] [Abstract][Full Text] [Related]
13. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
Allen N; Walker SR; Liberti L; Salek S
Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
[TBL] [Abstract][Full Text] [Related]
14. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
[TBL] [Abstract][Full Text] [Related]
15. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation and incorporation of health technologies: process and methodology adopted by a high-complexity care university].
Nunes AA; de Mello LM; Ana LW; Marques PM; Dallora ME; Martinez EZ; Pazin Filho A; Coelho EB
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S179-86. PubMed ID: 25402247
[TBL] [Abstract][Full Text] [Related]
17. Development, implementation and evaluation of an evidence-based program for introduction of new health technologies and clinical practices in a local healthcare setting.
Harris C; Garrubba M; Allen K; King R; Kelly C; Thiagarajan M; Castleman B; Ramsey W; Farjou D
BMC Health Serv Res; 2015 Dec; 15():575. PubMed ID: 26707549
[TBL] [Abstract][Full Text] [Related]
18. An equity framework for health technology assessments.
Culyer AJ; Bombard Y
Med Decis Making; 2012; 32(3):428-41. PubMed ID: 22065143
[TBL] [Abstract][Full Text] [Related]
19. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
[TBL] [Abstract][Full Text] [Related]
20. Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
Schmitz S; McCullagh L; Adams R; Barry M; Walsh C
Pharmacoeconomics; 2016 Sep; 34(9):925-37. PubMed ID: 27034245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]